Early Prediction of Placenta Accreta by Ultrasound and Color Doppler
1 other identifier
observational
148
1 country
1
Brief Summary
Placenta accreta is a substantially life threatening condition and one of the causes of maternal morbidity and mortality in the world. According to study done in United Kingdom, The estimated incidence of placenta accreta/increta/percreta was 1.7 per 10,000 maternities overall and 577 per 10,000 in women with both a previous cesarean delivery and placenta previa. in a tertiary south Italian center, The incidence increased from 0.12% during the 1970s, to 0.31% during the 2000s.While in United States of America, the prevalence of placenta accreta was 3.7 per 1000 deliveries.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2017
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2017
CompletedFirst Submitted
Initial submission to the registry
January 24, 2017
CompletedFirst Posted
Study publicly available on registry
January 26, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2020
CompletedMay 13, 2020
May 1, 2020
3 years
January 24, 2017
May 11, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Confirmation of occurrence of placenta accreta during delivery.
duration of pregnancy
Study Arms (2)
placenta accreta
Having at least one sign suggestive of placenta accreta
normal placenta
Never having any of the signs suggestive of placenta accreta
Interventions
the eligible participants will be searched for signs suggestive of placenta accreta; low implantation of the gestational sac (\<4cm from the external os), presence of placental lakes, Disruption of placental-myometrial interface and trophoblast overlapping a uterine scar by 2 dimensional transvaginal ultrasound and Intraplacental dilated vessels, turbulent blood flows and greatly increased periplacental vascularity by Doppler ultrasound by level II sonographer and co-investigator under his supervision using ultrasound device.
Eligibility Criteria
first trimester pregnancy between 11 weeks and 13 weeks.
You may qualify if:
- Low implantation of the gestational sac (\<4 cm from external os) by transvaginal ultrasound
- Presence of placental lakes by transvaginal ultrasound
- Disruption of placental-myometrial interface by transvaginal ultrasound
- Trophoblast overlapping a uterine scar (Cesarean section, myomectomy) by transvaginal ultrasound
- Intraplacental dilated vessels by Doppler ultrasound
- Turbulent blood flows by Doppler ultrasound
- Greatly increased periplacental vascularity by Doppler ultrasound
You may not qualify if:
- a) Cases far away from our hospital and expected to be lost to be followed. b) Pregnant women who will refuse to Participate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Assiut University
Asyut, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- clinical professor
Study Record Dates
First Submitted
January 24, 2017
First Posted
January 26, 2017
Study Start
January 1, 2017
Primary Completion
December 31, 2019
Study Completion
March 31, 2020
Last Updated
May 13, 2020
Record last verified: 2020-05